3[1]Bymaster FP,Calligaro DO,Falcone JF,et al.Radioreceptor binding profile of the atypical antipsychotic olanzapine.Neuropsychopharmacology ,1996,14:87
4[2]Kapur S,Zipursky RB,Remington G,et al.Clinical and theor etical implications of 5-HT2 and D2 receptor occupancy of clozapine,risperi dole,and olanzapine in schizophreia.Am J Psychiatry,1999,156:286
5[3]Arnt J,Skarsfeldt J.Do noval antipsychotics have similar pharmacological characteristics?a review of the evidence.Neuropsychopharmacolog y,1998,16:63
6[4]Bymaster FP.In vivo and in vitro biochemistry of olanzap ine.J Clin Psychiatry,1997,58(suppl 10):28
7[5]Tandon R,Milner K,Jibson MD.Antipsychotics from theory t o practice:integrating clinical and basic data.J Clin Psychiatry,1999,60(suppl 8 ):21
8[6]Beasley CM,Tollefson GD,Tran PV,et al.The efficacy of ol anzapine:the summary of global,multicentral clinical trials.J Clin Psychiatry,19 97,58(suppl 10):7
9[7]Sanger TM,Lieberman JA,Tohen M,et al.Olanzapine versus h aloperidol treatment in first-episode psychosis.Am J Psychiatry,1999,156:79
10[8]Tran PV,Hamilton SH,Runtz AJ,et al.Double-blind compari son of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.J Clin Psychopharmacol,1997,17:407
3WHITE, H,BARHASH GI,CALIF BM,et al.Age and outcome with contemporary thrombolytic therapy:Resuhs from the GUSTO trial [J ].Circulation, 1996,94 : 1826-1833.
4刘协和,译.牛津精神病学[M].成都:四川大学出版社,2001:617-618.
5HOLMES DR,WHITE D,PIEPEL KS,et al.Efects of age on outcome with primary angiography versus thromolysis [J].J Am Coil Cardiol, 199,33:412-419.
